News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gilead Sciences, Inc. (GILD) Chief: $180 Million Man


3/18/2014 6:59:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

In what's shaping up as a year of oversized paydays for chief executives, Gilead Sciences CEO John Martin has emerged as one of 2013's biggest winners.

Martin pulled in compensation valued at nearly $180 million in 2013, including stock option gains worth $158 million, the biotech giant said Friday. Martin received $15.4 million in salary, incentive awards, stock and stock options -- about what he's made in each of the past three fiscal years. But he cashed in on stock options for a $158.9 million gain and received another $4.8 million from shares that vested last year, Gilead said in a preliminary proxy filing.

Help employers find you! Check out all the jobs and post your resume.

Read at USA Today
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES